The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System

@inproceedings{Jubair2017TheTP,
  title={The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System},
  author={Luqman Khaleel Jubair and Nicholas A. Saunders},
  booktitle={Molecular therapy. Nucleic acids},
  year={2017}
}
The field of gene editing is undergoing unprecedented growth. The first ex vivo human clinical trial in China started in 2016, more than 1000 US patents have been filed, and there is exponential growth in publications. The ability to edit genes with high fidelity is promising for the development of new treatments for a range of diseases, particularly inherited conditions, infectious diseases, and cancers. For cancer, a major issue is the identification of driver mutations and oncogenes to… CONTINUE READING
BETA
2
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 96 REFERENCES

Application of CRISPR/Cas9 Technology to HBV.

  • International journal of molecular sciences
  • 2015
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9.

  • Biochemical and biophysical research communications
  • 2014
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…